CLINICAL_TRIALS
trial_result
· 2022-03-22
Clinical Trial Update: Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm [Phase 3]
Summary
Phase 3 trial update on tolperisone shows efficacy and safety data in subjects with pain due to acute back muscle spasm.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurana Pharmaceuticals, Inc. | Conditions: Back Muscle Spasm, Back Pain | Phase 3 | Status: COMPLETED